Related Experiment Video
Updated: Nov 1, 2025

12:19
Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
Published on: June 7, 2024
1.5K
Modelling the interplay between the CD4 /CD8 T-cell ratio and the expression of MHC-I in tumours
Christian John Hurry1, Alexander Mozeika2, Alessia Annibale3,4
1Department of Mathematics, King's College London, Strand, London, WC2R 2LS, UK. christian.hurry@kcl.ac.uk.
Journal of Mathematical Biology
|June 18, 2021
Summary
Mathematical modeling reveals that the CD4+/CD8+ T-cell ratio, T-cell infiltration, and MHC-I expression are key to eliminating tumors. A critical MHC-I level, influenced by the T-cell ratio, determines tumor immune escape.
Area of Science:
- Immunology
- Mathematical Biology
- Systems Biology
Background:
- The anti-tumor immune response involves complex cellular kinetics.
- Understanding the interplay of T-cells and tumor cells is crucial for effective cancer immunotherapy.
Purpose of the Study:
- To develop a mathematical model of the T-cell mediated anti-tumor immune response.
- To identify key factors influencing tumor elimination and immune escape.
Main Methods:
- Utilizing dynamical systems theory and non-equilibrium statistical mechanics.
- Modeling cellular kinetic reactions within the immune system.
- Analyzing the roles of CD4+/CD8+ T-cell ratio, T-cell infiltration, and MHC-I expression.
Main Results:
- A critical threshold of MHC-I expression was identified, determining tumor immune escape.
- This critical MHC-I level is dependent on the helper/cytotoxic T-cell ratio.
- The model indicates robustness against minor fluctuations in the T-cell ratio.
- T-cell infiltration and TCR repertoire specificity impact the critical MHC-I expression level.
Conclusions:
- The interplay between T-cell ratios, infiltration, and MHC-I expression is vital for anti-tumor immunity.
- MHC-I expression dynamics may explain variations in tumor growth patterns.
- Mathematical modeling provides insights into the complex mechanisms of anti-tumor immune responses.

